| Avista Corporation |
| Date/Time | / |
| Chg. / Chg.(%) | - / |
| Bid | - |
| Ask | - |
| Open | - |
| Previous Close | - |
| High | - |
| Low | - |
| Volume [USD] | - |
| Volume [Units] | |
| Price fixings | |
| ISIN | US05379B1070 |
| Security | AVA |
| Exchange | IEX |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 40.71 |  |
|
| NYSE | 45.83 |  |
597,231 |
| Cboe US | 45.85 | |
35,988 |
| IEX | 45.85 | |
15,012 |
| Frankfurt | 41.135 | |
0 |
| Stuttgart | 40.905 |  |
0 |
| Berlin | 40.600 | |
0 |
| Düsseldorf | 41.210 | |
0 |
| TradeGate | 40.76 | 49 |
News
- Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
07/15/2019 / 22:10 - GlobeNewswire - Avista Corp. Second Quarter 2019 Earnings Conference Call and Webcast Announced
07/10/2019 / 22:05 - GlobeNewswire - Avista reaches partial settlement in Oregon rate case
07/03/2019 / 22:05 - GlobeNewswire - Avista Files Annual Rate Adjustments in Idaho
07/01/2019 / 22:05 - GlobeNewswire - Cambrex Strengthens Leadership Team to Support Integrated Small Molecule End-to-End Service Offering
06/26/2019 / 14:00 - GlobeNewswire
Real-time